Prof. Dr. ÖZLEM ER

Yayın Ağı

Makaleler 26

1. Real-World Outcomes in BRAF-Mutant Non-small Cell Lung Cancer: A Multicenter Analysis From the Turkish Oncology Group

Telli T. A., TATLI A. M., Alan Ö., Keskin G. Y., Karadurmuş N., Karakaya S., et al.

Clinical Lung Cancer , cilt.26, sa.8, 2025 (SCI-Expanded, Scopus)

2. Real-world efficacy and safety data of immune checkpoint inhibitors in Turkish patients with metastatic melanoma: A Turkish oncology group retrospective study

Ozgun A., Mustafayev F. N. A., Dogan I., Vatansever S., Eryilmaz M. K., ERDOĞAN A. P., et al.

Molecular and Clinical Oncology , cilt.22, sa.6, 2025 (ESCI, Scopus)

3. Total Neoadjuvant Therapy Versus Neoadjuvant Chemoradiation for Locally Advanced Rectal Cancer: A Multi-Institutional Real-World Study

Şenocak Taşçı E., Mutlu A. U., Saylık O., Ölmez Ö. F., Bilici A., Sünger E., et al.

Cancers , cilt.16, sa.18, 2024 (SCI-Expanded, Scopus)

4. Beyond traditional therapies: clinical significance of complex molecular profiling in patients with advanced solid tumours-results from a Turkish multi-centre study

ÖLMEZ Ö. F., BİLİCİ A., ER Ö., BİŞGİN A., Sevinc A., Akman T., et al.

JAPANESE JOURNAL OF CLINICAL ONCOLOGY , sa.5, ss.562-568, 2024 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

5. Genetic testing and counseling challenges in personalized breast cancer care: review article with insights from Türkiye

Cicin I., Karadurmus N., BİLİCİ A., Bahsi T., Sendur M. A., Demirci U., et al.

Future Oncology , cilt.20, sa.15, ss.1031-1045, 2024 (SCI-Expanded, Scopus)

6. Short-Course Radiotherapy Followed by Consolidation Chemotherapy Is Safe and Effective in Locally Advanced Rectal Cancer: Comparative Short-term Results of Multicenter Propensity Score Case-Matched Study.

Benlice C., Koc M. A., Gulcu B., Bilgin İ. A., Akyol C., Baca B., et al.

Diseases of the colon and rectum , cilt.66, sa.5, ss.681-690, 2023 (SCI-Expanded, Scopus)

7. Efficacy of subsequent treatments in patients with hormone-positive advanced breast cancer who had disease progression under CDK 4/6 inhibitor therapy.

Karacin C., Oksuzoglu B., Demirci A., Keskinkılıç M., Baytemür N. K., Yılmaz F., et al.

BMC cancer , cilt.23, sa.1, ss.136, 2023 (SCI-Expanded, Scopus)

8. Real life experience of patients with locally advanced gastric and gastroesophageal junction adenocarcinoma treated with neoadjuvant chemotherapy: a Turkish oncology group study

Basoglu T., Sakin A., Erol C., Ozden E., ÇABUK D., Cilbir E., et al.

JOURNAL OF CHEMOTHERAPY , sa.2, ss.142-149, 2023 (SCI-Expanded, Scopus)

9. Favorable locoregional control in clinically node-negative hormone-receptor positive breast cancer with low 21-gene recurrence scores: a single-institution study with 10-year follow-up

URAS C., Cabioglu N., TOKAT F., ER Ö., KARA H., KORKMAZ T., et al.

BMC CANCER , cilt.22, sa.1, 2022 (SCI-Expanded, Scopus)

10. Atezolizumab combined with chemotherapy in the first-line treatment of extensive-stage small cell lung cancer: a real-life data of the Turkish Oncology Group

Gurbuz M., Kutlu Y., Akkus E., KÖKSOY E. B., Kose N., Oven B. B., et al.

JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY , cilt.148, sa.12, ss.3547-3555, 2022 (SCI-Expanded, Scopus)

11. MGMT in glial carcinogenesis. Roles from prevention to treatment.

Elmaci İ., Altinoz M. A., Kahraman Ozlu E. B., Sari R., Er Ö., Gokhan Ekmekci C., et al.

European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation (ECP) , cilt.31, ss.568-576, 2022 (SCI-Expanded, Scopus)

12. Optimizing the Personalized Care for the Management of Rectal Cancer: A Consensus Statement

Aytaç E., Özer L., Baca B., Balık E., Kapran Y., Taşkın O. C., et al.

TURKISH JOURNAL OF GASTROENTEROLOGY , cilt.33, sa.8, ss.627-663, 2022 (SCI-Expanded, Scopus, TRDizin)

13. COVID-19 Vaccinations: Summary Guidance for Cancer Patients in 28 Languages: Breaking Barriers to Cancer Patient Information

Mauri D., Kamposioras K., Tsali L., Dambrosio M., De Bari B., Hindi N., et al.

Reviews on Recent Clinical Trials , cilt.17, sa.1, ss.11-14, 2022 (ESCI, Scopus)

14. Treatment Strategies for Dopamine Agonist-Resistant and Aggressive Prolactinomas: A Comprehensive Analysis of the Literature

Sari R., Altinoz M. A., Ozlu E. B. K., Sav A., ERŞEN DANYELİ A., Baskan O., et al.

HORMONE AND METABOLIC RESEARCH , cilt.53, sa.7, ss.413-424, 2021 (SCI-Expanded, Scopus)

15. Large solitary scalp metastasis of renal cell carcinoma: A case report

ALTINKAYA A., Yazar S., Karadag E. C., ER O.

NIGERIAN JOURNAL OF CLINICAL PRACTICE , cilt.24, sa.4, ss.629-631, 2021 (SCI-Expanded, Scopus)

16. Benign leiomyoma with multiple metastases to vertebrae and calvarium: An index case with comprehensive review of endocrine targets

Elmaci I., Altinoz M., Ozlu B., Sari R., Er O., Danyeli A., et al.

NEUROSURGICAL REVIEW , cilt.44, sa.1, ss.289-300, 2021 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

17. Clinicopathological and Prognostic Significance of MSI Status and PD-L1 Expression in Turkish Patients with Gastric Cancer

Bahsi S., YILDIZ İ., Erdamar S., Goksel S., Tozun N., AYTAÇ E., et al.

UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI , cilt.31, sa.4, ss.246-254, 2021 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

18. Efficacy of Palbociclib and Endocrine Treatment in Heavily Pretreated Hormone Receptor-positive/HER2-negative Advanced Breast Cancer: Retrospective Multicenter Trial

Demir A., Mandel N. M., PAYDAŞ S., Demir G., ER O., Turhal N. S., et al.

Balkan medical journal , cilt.37, sa.2, ss.104-107, 2020 (SCI-Expanded, Scopus, TRDizin) Sürdürülebilir Kalkınma

19. Efficacy of Palbociclib and Endocrine Treatment in Heavily Pretreated Hormone Receptor-positive/HER2-negative Advanced Breast Cancer: Retrospective Multicenter Trial.

Demir A., Molinas Mandel N., Paydaş S., Demir O. G., Er Ö., Turhal N. S., et al.

Balkan Medical Journal , cilt.37, sa.2, ss.104-107, 2020 (SCI-Expanded, Scopus, TRDizin) Sürdürülebilir Kalkınma

20. Dealing with the gray zones in the management of gastric cancer: The consensus statement of the Istanbul Group

AYTAÇ E., Aslan F., ÇİÇEK B., Erdamar S., Gurses B., GÜVEN K., et al.

TURKISH JOURNAL OF GASTROENTEROLOGY , cilt.30, sa.7, ss.584-598, 2019 (SCI-Expanded, Scopus, TRDizin)

21. F-18-fluorodeoxyglucose-positron emission tomography avid paraspinal soft-tissue mass mimicking a malign neoplasm: non-traumatic myositis ossificans

Ozbayrak M., Guner A. L., Unal V. S., Tokat F., Er Ö., Karaarslan E.

SPINE JOURNAL , cilt.16, sa.10, 2016 (SCI-Expanded, Scopus)

22. Cutaneous melanoma in Turkey: analysis of 1157 patients in the Melanoma Turkish Study

Abali H., ÇELİK İ., Karaca B., TURNA Z. H., KAYTAN SAĞLAM E., Akman T., et al.

JOURNAL OF BUON , cilt.20, sa.4, ss.1137-1141, 2015 (SCI-Expanded, Scopus)

23. Bone health in breast cancer patients: A comprehensive statement by CECOG/SAKK Intergroup

Rordorf T., Hassan A. A., Azim H., Alexandru E., ER O., Gokmen E., et al.

BREAST , cilt.23, sa.5, ss.511-525, 2014 (SCI-Expanded, Scopus)

24. Küçük hücreli akciğer kanserinin mide metastazı Olgu sunumu

ÇALIKUŞU Z., ATALAR B., TİFTİKÇİ A., UĞURLUER G., Er Ö., Göksel S.

Acıbadem Üniversitesi Sağlık Bilimleri Dergisi , 2012 (Hakemli Dergi) Sürdürülebilir Kalkınma

25. Epidermoid carcinoma of the lung with isolated penile metastasis.

Sofikerim M., Gülmez I., Tokat F., Er Ö., Gülmez I.

The Canadian journal of urology , cilt.14, ss.3643-5, 2007 (SCI-Expanded, Scopus)

26. Presentation with superior vena cava syndrome secondary to solitary lung metastasis mimicking primary lung cancer following resection of a uterine malignant mixed mullerian tumor: brief case report.

Ozkan M., Er Ö., Kaplan B., Altinbas M., Ozcelik B., Tokat F., et al.

European journal of obstetrics, gynecology, and reproductive biology , cilt.118, ss.260-4, 2005 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

Hakemli Bilimsel Toplantılarda Yayımlanmış Bildiriler 16

1. Artificial intelligence algorithms for recurrence risk score prediction in early-stage breast cancer: A multicenter study of 437 cases

Bayram E., Basaran G., Gokmen E., Mandel N. M., Oyan B., Uskent N., et al.

Special Clinical Science Symposia, ELECTR NETWORK, 29 Mayıs 2024, (Özet Bildiri)

2. RISK FACTORS AND HISPATHOLOGICAL CHARACTERISTICS OF EARLY-ONSET COLORECTAL CANCER

Koç E. S., Tiftikçiş A., Er Ö., Tözün A. N.

United European Gastroenterology Week , Kobenhavn, Danimarka, 15 - 19 Ekim 2023, cilt.11, sa.58, ss.1116, (Özet Bildiri)

3. FAVORABLE LOCOREGIONAL CONTROL IN CLINICALLY NODE-NEGATIVE HORMONE-RECEPTOR POSITIVE BREAST CANCER WITH LOW 21-GENE RECURRENCE SCORES: A SINGLE INSTITUTIONAL STUDY WITH 10-YEAR FOLLOW-UP

Uras C., Cabioglu N., Tokat F., Kara H., Er O., Korkmaz T., et al.

San Antonio Breast Cancer Symposium, San-Antonio, Kuzey Mariana Adaları, 6 - 10 Aralık 2022, (Özet Bildiri)

4. Relationship of Vitamin D Receptor Gene Polymorphisms with Adverse Drug Responses In Patients With Colorectal Cancer

Tosun M., ÇEVİK M., SÖNMEZ Ö., ER Ö., DEMİR O. G., OYAN ULUÇ B., et al.

9th International Molecular Biology and Biotechnology Congress, 6 - 10 Aralık 2020, (Özet Bildiri) Sürdürülebilir Kalkınma

5. The effect of the use of complex molecular profiling in advanced solid organ tumours on clinical decision: Turkey molecular profiling in advanced cancers trial (TUMPACT)

Olmez O. F., Bilici A., ER O., Sevinc A., Akman T., Uslu R., et al.

ESMO Virtual Congress, ELECTR NETWORK, 19 Eylül - 18 Ekim 2020, cilt.31, (Özet Bildiri)

6. Clinicopathological and prognostic significance of microsatellit instability (MSI) status and PDI-1 expression in Turkish patients with gastric cancer.

Yildiz İ., Bahsi S., Erdamar S., Goksel S., Demir G., Er Ö., et al.

Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Illinois, Amerika Birleşik Devletleri, 31 Mayıs - 04 Haziran 2019, cilt.37, (Özet Bildiri) Sürdürülebilir Kalkınma